Transitional Cell Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Transitional Cell Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-21Clinical Trial Update: Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder [Phase 2]
This entry summarizes a completed Phase 2 trial evaluating robotic-assisted laparoscopic extended pelvic lymph node dissection for transitio…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial of ixabepilone in advanced urinary tract cancers has completed, evaluating its activity across several urothelial and…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Gene Therapy in Treating Patients With Advanced Bladder Cancer [Phase 1]
Phase 1 gene therapy trial update for advanced bladder cancer has completed, including patients with recurrent and various stages of the dis…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating trastuzumab with chemotherapy in locally recurrent or metastatic urinary tract cancers has completed, incl…
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder [Phase 2]
A Phase 2 study evaluating pralatrexate for advanced or metastatic relapsed transitional cell carcinoma of the urinary bladder has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Tesetaxel for Previously Treated Patients With Bladder Cancer [Phase 2]
Phase 2 clinical trial update for Tesetaxel in previously treated bladder cancer (transitional cell carcinoma) patients; the trial status is…
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder [Phase 1]
Phase 1 study evaluating Mycobacterium w in patients with BCG-refractory superficial transitional cell carcinoma of the bladder has been com…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer [EARLY_Phase 1]
Early-phase trial evaluating mitomycin C with hyperthermia and intravesical mitomycin C for recurrent bladder cancer has completed, with res…
-
CLINICAL_TRIALS research · 2010-10-07Clinical Trial Update: The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma
This clinical trial update reports on the expression and potential effects of Cyr61 in urinary tract transitional cell carcinoma, reflecting…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder [Phase 1]
This entry reports the completion of a Phase I trial evaluating suramin for superficial transitional cell carcinoma of the bladder.
-
CLINICAL_TRIALS trial_result · 2006-09-27Clinical Trial Update: Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer [Phase 3]
Phase 3 trial comparing adjuvant versus progression-triggered gemcitabine monotherapy for locally advanced bladder cancer; trial status is c…
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating sequential gemcitabine and cisplatin followed by pemetrexed and gemcitabine in patients with advanced or metastat…
-
CLINICAL_TRIALS trial_result · 2006-06-22Clinical Trial Update: Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder [Phase 2]
A completed Phase 2 trial evaluated intravesical epirubicin plus BCG for preventing recurrence in patients with transitional cell carcinoma …